| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 393,677 | 387,707 | 463,170 | 324,027 | | Cost of Revenue | 198,047 | 213,059 | 227,295 | 218,652 | | | Gross Profit | 195,630 | 174,648 | 235,875 | 105,375 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 144,697 | 126,102 | 250,958 | 197,872 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 6,207 | 8,195 | 4,041 | 1,374 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 44,726 | 40,351 | (19,124) | (93,871) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 382 | 7,884 | 723 | 4,409 | | Earnings Before Interest And Taxes | 43,180 | 46,518 | (21,604) | (91,157) | | Interest Expense | 13,297 | 10,709 | 5,524 | 4,302 | | Income Before Tax | 29,883 | 35,809 | (27,128) | (95,459) | | Income Tax Expense | 674 | 1,337 | 1,432 | (2,039) | | Minority Interest | 4,384 |
-
| (9,044) |
-
| | | | Net Income From Continuing Ops | 37,406 | 34,472 | (28,560) | (93,420) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 33,593 | 34,472 | (28,560) | (93,420) | | Preferred Stock And Other Adjustments | (1,877) | 1,877 |
-
|
-
| | | Net Income Applicable To Common Shares | $31,716 | $36,349 | ($28,560) | ($93,420) |
|
0.03% Nasdaq 
Income Statement
